Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.
Gupta A, Bagri NK, Tripathy SK, Barwad A, Phulware RH, Hari P.
Rheumatol Int. 2020 Jan;40(1):153-159. doi: 10.1007/s00296-019-04363-z. Epub 2019 Jul 4.
Clinical outcomes of secondary amyloidosis in inflammatory arthritis: A case series from Western India.
Kadam S, Sachdev G, Balakrishnan C, Yadav S, Patil P, Patankar A, Swain B.
Int J Rheum Dis. 2024 Jun;27(6):e15227. doi: 10.1111/1756-185X.15227.
Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review.
Chantarogh S, Vilaiyuk S, Tim-Aroon T, Worawichawong S.
BMC Nephrol. 2017 May 12;18(1):159. doi: 10.1186/s12882-017-0573-y.
Amyloidosis as a cause of death in patients with rheumatoid arthritis.
Koivuniemi R, Paimela L, Suomalainen R, Leirisalo-Repo M.
Clin Exp Rheumatol. 2008 May-Jun;26(3):408-13.
From arthritis to Alzheimer's disease: current concepts on the pathogenesis of amyloidosis.
Kisilevsky R.
Can J Physiol Pharmacol. 1987 Sep;65(9):1805-15. doi: 10.1139/y87-282.
Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis.
Smith GR, Tymms KE, Falk M.
Intern Med J. 2004 Sep-Oct;34(9-10):570-2. doi: 10.1111/j.1445-5994.2004.00605.x.
Successful Treatment of Rheumatoid Arthritis-Associated Renal AA Amyloidosis with Tocilizumab.
Kovács A, Cserenyecz A, Baksay B, Kemény É, Szekanecz Z.
Isr Med Assoc J. 2020 Jul;22(7):455-457.
Amyloidosis and rheumatoid arthritis.
Husby G.
Clin Exp Rheumatol. 1985 Apr-Jun;3(2):173-80.
Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine. A case report.
Shapiro DL, Spiera H.
Arthritis Rheum. 1995 Dec;38(12):1851-4. doi: 10.1002/art.1780381220.
[Causes and treatment of systemic amyloidosis].
Blank N, Hegenbart U, Schönland S.
Z Rheumatol. 2016 Mar;75(2):141-50. doi: 10.1007/s00393-015-0024-8.
